The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorder

被引:0
|
作者
Soares, C.
Thase, M. [1 ]
Kornstein, S. [2 ]
Brisard, C. [3 ]
Septien-Velez, L. [3 ]
Germain, J. M. [3 ]
Pitrosky, B. [3 ]
Patroneva, A. [4 ]
Jiang, Q. [4 ]
Ninan, P. [4 ]
Ganguly, R. [4 ]
机构
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[3] Wyeth Ayerst Res, Paris, France
[4] Wyeth Ayerst Res, Collegeville, PA USA
关键词
D O I
10.1016/S0924-977X(08)70478-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S342 / S343
页数:2
相关论文
共 50 条
  • [41] Quality of life and subjective sleep-related measures in bipolar disorder and major depressive disorder
    Jermann, Francoise
    Perroud, Nader
    Favre, Sophie
    Aubry, Jean-Michel
    Richard-Lepouriel, Helene
    QUALITY OF LIFE RESEARCH, 2022, 31 (01) : 117 - 124
  • [42] Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
    Bo, Qijing
    Tian, Lu
    Li, Feng
    Mao, Zhen
    Wang, Zhimin
    Ma, Xin
    Wang, Chuanyue
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1649 - 1657
  • [43] Treating pain in patients with major depressive disorder: Efficacy of desvenlafaxine succinate, a new serotonin and norepinephrine reuptake inhibitor
    Septien-Velez, L.
    Pitrosky, B.
    Padmanabhan, S. K.
    Germain, J. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S136 - S136
  • [44] Efficacy of sertraline in improving Quality of Life and functioning in generalized anxiety disorder (GAD)
    Sjodin, I
    Kutcher, SP
    Ravindran, A
    Burt, T
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S365 - S366
  • [45] The effect of antidepressant treatment on quality of life in patients with major depressive disorder
    Aydemir, O.
    Ergun, H.
    Kesebir, S.
    Soygur, H.
    Tulunay, C. F.
    BIPOLAR DISORDERS, 2010, 12 : 5 - 5
  • [46] Effect of group psychotherapy on the life quality of patients with major depressive disorder
    Sharif, F.
    Nourian, K. H.
    Tabatabaee, H. R.
    Dehbozorghi, S.
    BIPOLAR DISORDERS, 2008, 10 : 54 - 55
  • [47] Efficacy and safety of desvenlafaxine succinate in the short-term treatment of major depressive disorder in adults
    Septien-Velez, L.
    Pitrosky, B.
    Padmanabhan, S. K.
    Germain, J. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S234 - S234
  • [48] Economic evaluation of desvenlafaxine in the treatment of major depressive disorder in Spain
    Rejas Gutierrez, Javier
    Blanca Tamayo, Milagrosa
    Gascon Barrachina, Josep
    Armada Pelaez, Beatriz
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2016, 9 (02): : 87 - 96
  • [49] Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder
    Soares, Claudio N.
    Thase, Michael E.
    Clayton, Anita
    Guico-Pabia, Christine J.
    Focht, Kristen
    Jiang, Qin
    Kornstein, Susan G.
    Ninan, Phil
    Kane, Cecelia P.
    Cohen, Lee S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (04): : 700 - 711
  • [50] Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder
    Xiao Wei Tan
    Esmond Seow
    Edimansyah Abdin
    Swapna Verma
    Kang Sim
    Siow Ann Chong
    Mythily Subramaniam
    BMC Psychiatry, 19